BIND Biosciences
BIND Biosciences (NASDAQ: BIND) is a biopharmaceutical company founded to develop therapeutic targeted nanoparticles to produce best in class drugs. Initial product development efforts are in the areas of oncology, cardiovascular disorders, inflammatory disease and RNAi therapeutics.
